DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
RG-7376
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase RAF inhibitor
RG-7376
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RPR749
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor agonist
RPR749
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
FANAPANEL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FANAPANEL
×
Maximum Phase:
1
First Approval:
None
UNII:
E3AP71EM0O
Molecule Type:
Small molecule
Molecular Formula:
C14H15F3N3O6P
Molecular Weight:
409.26
AlogP:
0.68
PSA:
124.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
SENEXIN B
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
SENEXIN B
×
Maximum Phase:
1
First Approval:
None
UNII:
E2X758P2BZ
Molecule Type:
Small molecule
Molecular Formula:
C27H26N6O
Molecular Weight:
450.55
AlogP:
3.7
PSA:
85.15
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
1,1'-METHYLENEBIS(4-((HYDROXYIMINO)METHYL)-PYRIDINIUM)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C13H14N4O2+2
Molecular Weight:
258.28
AlogP:
0.38
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
CALANOLIDE A
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CALANOLIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
S5A9TQN46W
Molecule Type:
Small molecule
Molecular Formula:
C22H26O5
Molecular Weight:
370.45
AlogP:
4.38
PSA:
68.9
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GS-9901
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular
Unknown
GS-9901
×
Maximum Phase:
1
First Approval:
None
UNII:
U09Q76B8VK
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClFN9O
Molecular Weight:
477.89
AlogP:
2.96
PSA:
161.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TTC-352
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
TTC-352
×
Maximum Phase:
1
First Approval:
None
UNII:
65ILH3Y0MI
Molecule Type:
Small molecule
Molecular Formula:
C20H13FO3S
Molecular Weight:
352.39
AlogP:
5.91
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PENCLOMEDINE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Unknown
PENCLOMEDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
66Q80IL7CW
Molecule Type:
Small molecule
Molecular Formula:
C8H6Cl5NO2
Molecular Weight:
325.41
AlogP:
4.23
PSA:
31.35
HBD:
0.0
HBA:
#RotB:
2.0
Source:
MK-8353
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
MAP kinase ERK1 inhibitor
MK-8353
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORE1001
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ORE1001
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APTO-253
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
APTO-253
×
Maximum Phase:
1
First Approval:
None
UNII:
WB59MRW00U
Molecule Type:
Small molecule
Molecular Formula:
C22H14FN5
Molecular Weight:
367.39
AlogP:
5.26
PSA:
70.25
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TRICIRIBINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRICIRIBINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GENZ-644282
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GENZ-644282
×
Maximum Phase:
1
First Approval:
None
UNII:
717I541I2R
Molecule Type:
Small molecule
Molecular Formula:
C22H21N3O5
Molecular Weight:
407.43
AlogP:
2.67
PSA:
83.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
H3B-6527
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
H3B-6527
×
Maximum Phase:
1
First Approval:
None
UNII:
4HTE364XIK
Molecule Type:
Small molecule
Molecular Formula:
C29H34Cl2N8O4
Molecular Weight:
629.55
AlogP:
5.48
PSA:
124.19
HBD:
3.0
HBA:
#RotB:
10.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BUTANE
1
Small molecule
Investigational
Unknown
Unknown
Essential Hypertension
Unknown
BUTANE
×
Maximum Phase:
1
First Approval:
None
UNII:
6LV4FOR43R
Molecule Type:
Small molecule
Molecular Formula:
C4H10
Molecular Weight:
58.12
AlogP:
1.81
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
1.0
Source:
LY-2874455
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Fibroblast growth factor receptor inhibitor
LY-2874455
×
Maximum Phase:
1
First Approval:
None
UNII:
E9M363811V
Molecule Type:
Small molecule
Molecular Formula:
C21H19Cl2N5O2
Molecular Weight:
444.32
AlogP:
4.76
PSA:
88.85
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MUBRITINIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Kidney Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms
Receptor protein-tyrosine kinase erbB-2 inhibitor
MUBRITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
V734AZP9BR
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N4O2
Molecular Weight:
468.48
AlogP:
6.06
PSA:
65.97
HBD:
0.0
HBA:
#RotB:
10.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALDOSTERONE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ALDOSTERONE
×
Maximum Phase:
1
First Approval:
None
UNII:
4964P6T9RB
Molecule Type:
Small molecule
Molecular Formula:
C21H28O5
Molecular Weight:
360.45
AlogP:
1.85
PSA:
91.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SB-743921
1
Small molecule
Investigational
Unknown
Unknown
Hodgkin Disease; Lymphoma, Non-Hodgkin; Neoplasms
Unknown
SB-743921
×
Maximum Phase:
1
First Approval:
None
UNII:
24DSZ1VN92
Molecule Type:
Small molecule
Molecular Formula:
C31H33ClN2O3
Molecular Weight:
517.07
AlogP:
6.53
PSA:
76.54
HBD:
1.0
HBA:
#RotB:
9.0
Source:
NNZ-2591
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NNZ-2591
×
Maximum Phase:
1
First Approval:
None
UNII:
2T1HU6069S
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O2
Molecular Weight:
194.23
AlogP:
0.05
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BMS-779788
1
Small molecule
Investigational
Unknown
Unknown
Atherosclerosis
LXR-beta agonist
BMS-779788
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
69
70
71
72
73
74
75
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA